Severe epidermal necrolysis after treatment with imatinib and consecutive allogeneic hematopoietic stem cell transplantation
- 18 April 2003
- journal article
- case report
- Published by Springer Nature in Annals of Hematology
- Vol. 82 (5) , 303-304
- https://doi.org/10.1007/s00277-003-0643-z
Abstract
Imatinib is a new promising therapeutic option for chronic myeloid leukemia (CML) with efficacy even in the blast phase of the disease. However, most patients treated with imatinib in the blast phase develop progressive disease rapidly. Thus, treatment with imatinib has to be followed by other treatment strategies. The normally mild to moderate side effects of imatinib including skin rashes might therefore be aggravated. Here, we describe a patient with severe epidermal necrolysis after treatment with imatinib and consecutive allogeneic hematopoietic stem cell transplantation. Prolonged inhibition of platelet-derived growth factor by imatinib may be an explanation for this observed skin toxicity.Keywords
This publication has 8 references indexed in Scilit:
- Imatinib mesylate (STI571) therapy for Philadelphia chromosome–positive chronic myelogenous leukemia in blast phaseBlood, 2002
- Cerebral oedema as a possible complication of treatment with imatinibThe Lancet, 2002
- Acute Generalized Exanthematous Pustulosis Associated with STI571 in a Patient with Chronic Myeloid LeukemiaDermatology, 2001
- Clinicopathological Differential Diagnosis of Drug-Induced Toxic Epidermal Necrolysis (Lyell’s Syndrome) and Acute Graft-Versus-Host ReactionPublished by Springer Nature ,2001
- Clinical, Microbial, and Biochemical Aspects of the Exfoliative Toxins Causing Staphylococcal Scalded-Skin SyndromeClinical Microbiology Reviews, 1999
- Reduced Expression of PDGF and PDGF Receptors During Impaired Wound HealingJournal of Investigative Dermatology, 1997
- RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.Proceedings of the National Academy of Sciences, 1995
- Toxic epidermal necrolysis after bone marrow transplantation: Study of nine casesJournal of the American Academy of Dermatology, 1990